http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103923088-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2013-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103923088-B |
| titleOfInvention | 2,5-diazabicyclo [2.2.1] heptane class compound and preparation method, its Pharmaceutical composition and in application pharmaceutically |
| abstract | The present invention relates to class 2,5 diazabicyclo [2.2.1] heptane class derivant, its preparation method and in application pharmaceutically.Concrete, the present invention relates to new 2 shown in a kind of logical formula (I), 5 diazabicyclos [2.2.1] heptane class derivant, its preparation method and the pharmaceutical composition containing this derivant and its as therapeutic agent especially as the purposes of poly-(ADP ribose) polymerase (PARP) inhibitor. |
| priorityDate | 2013-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 153.